Company Cell MedX Corp. Other OTC
Equities
CMXC
US15115X1072
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58.8
%
| 0 | 60.6 % | 0 | 58.8 % | -55.85% |
eBalance Devices
41.2
%
| 0 | 39.4 % | 0 | 41.2 % | -52.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -54.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/14/24 |
George Adams
CHM | Chairman | 76 | 23/18/23 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/20/08 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/22/27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/22/27 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/20/08 |
George Adams
CHM | Chairman | 76 | 23/18/23 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/14/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 297,236,373 | 60,447,694 ( 20.34 %) | 0 | 20.34 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |